ScholarIQanswers from OpenAlex

Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma

PaperCitations, authors & open-access status

Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma have?

ScholarIQcitation count

Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma has 58 citations in the OpenAlex counts ScholarIQ stores.

When was Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma published?

ScholarIQyear

Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma has 2022 year in the ScholarIQ index.

What is the open-access status of Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma?

ScholarIQoa status

Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma has green oa status in the ScholarIQ index.

What is the DOI of Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma?

ScholarIQdoi

The DOI for Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma is on the source record.

What is the PMID of Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma?

ScholarIQpmid

The PMID for Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma is on the source record.

What is the OpenAlex record for Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma?

ScholarIQopenalex

The OpenAlex for Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial